You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • AB0422 Impact of Combination Etanercept-Dmard Induction Therapy in Active Rheumatoid Arthritis: Interim Results of an International Treat-to-Target Study Conducted in Regions with Limited Biologic Access

Article info

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Rheumatoid arthritis - anti-TNF therapy
AB0422 Impact of Combination Etanercept-Dmard Induction Therapy in Active Rheumatoid Arthritis: Interim Results of an International Treat-to-Target Study Conducted in Regions with Limited Biologic Access

Authors

Citation

Pavelka K, Akkoç N, Al-Maini M, et al
AB0422 Impact of Combination Etanercept-Dmard Induction Therapy in Active Rheumatoid Arthritis: Interim Results of an International Treat-to-Target Study Conducted in Regions with Limited Biologic Access
Annals of the Rheumatic Diseases 2015;74:1035.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions